The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review

<i>Background:</i> The role of denosumab in patients with resectable giant cell tumour of bone remains unclear. We asked the following research question: for patients (aged ≥ 12 years) with resectable giant cell tumour of bone, what are the benefits and harms of denosumab compared with n...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Abha Gupta, Lisa Durocher-Allen, Snezana Popovic, Richard Tozer, Xiaomei Yao, Michelle Ghert
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Subjects:	denosumab giant cell tumour of bone surgical outcomes systematic review
Online Access:	https://www.mdpi.com/1718-7729/28/2/124